The table below shows AGIOS PHARMACEUTICALS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$372.98M
-$389.84M
-$296.06M
-$309.48M
-$407.32M
-$290.76M
Capital expenditure
$4.32M
$1.69M
$999.00K
$4.88M
$5.74M
$14.11M
Investing cash flow
$377.18M
$363.44M
$239.57M
$243.26M
$1.25B
$75.75M
Dividends paid
-
-
-
-
-
AGIO operating cash flow (10-K history)
AGIOS PHARMACEUTICALS, INC. reported operating cash flow of -$372.98M for fiscal year 2025. That is up 4.3% from -$389.84M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $38.56M (FY 2016) to -$372.98M. Figures come from the company's audited annual reports as filed with the SEC.
